Control: Placebo administration

DRUG2 trials

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Conditions

Central Diabetes InsipidusHypopituitarismHypothalamic DiseasesOxytocin DeficiencyPanhypopituitarismPituitary DiseasesPsychological DisorderSocial Isolation

Phase 4

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

CompletedNCT04897802

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauCentral Diabetes Insipidus, Hypopituitarism, Hypothalamic Diseases +5

Start: 2021-09-13End: 2024-12-31Updated: 2026-01-20

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

CompletedNCT04902235

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauCentral Diabetes Insipidus, Hypopituitarism, Hypothalamic Diseases +5

Start: 2021-07-06End: 2023-05-01Updated: 2024-04-03

Related Papers

Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trial.

2025-01-185 citations